Zhengzhi Zou

11PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer cell biologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 08, 2026
KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibition.

Nana Chen, Mouxiang Fang, Leqi Zhong

|Oct 22, 2025
Machine learning constructs a ferroptosis related signature for predicting prognosis and drug sensitivity in lung cancer.

Zihao Li, Yibing Chen, Benxin Hou

|Jul 17, 2025
Ferroptosis in cancer: revealing the multifaceted functions of mitochondria.

Xinyi Ding, Lei Cui, Yanjun Mi

|Jun 09, 2024
Targeting PAX8 sensitizes ovarian cancer cells to ferroptosis by inhibiting glutathione synthesis.

Yanlin Luo, Xiaoli Liu, Yibing Chen

Pageof 2